CA
CANDY CANE: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease – Changing Glucose Management
Ian de Boer
ADA
CA
CANDY: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease
Ian de Boer
ADA
CA
CAP: Community Acquired Pneumonia Study
Pavan Bhatraju
NIDDK
CA
CATCH: A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis
Rajnish Mehrotra
GastroKlenz, Inc. (CloudCath)
Ce
Cellular and Molecular Mechanisms of COVID-19 Mediated Kidney Injury
Jonathan Himmelfarb
NCATS
Jonathan Himmelfarb, MD
Ch
Characterization of the impact of cortisol on kidney clearance
Edward J. Kelly
Drug Design/Metabolism/…
CH
CHROME: COVID-19 Host Response and Clinical Outcomes
Mark Wurfel
The Gates Foundation
CL
CLEAR: Clearance of 25-hydroxyvitamin D in chronic kidney disease
Ian de Boer
NIDDK
CO
CONCORD: Combination of Novel Therapies for CKD Comorbid Depression
Rajnish Mehrotra
NIDDK
Co
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
